Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Effect of Dexmedetomidine Versus Magnesium Sulphate as an Adjuvant to Lidocaine in Preemptive Peribulbar Block in Patients Undergoing Dacryocystorhinostomy Under General Anesthesia: A Randomized Controlled Trial

NCT07675616 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07675616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Effect of Dexmedetomidine Versus Magnesium Sulphate as an Adjuvant to Lidocaine in Preemptive Peribulbar Block in Patients Undergoing Dacryocystorhinostomy Under General Anesthesia: A Randomized Controlled Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Recruiting
Start date
May 16, 2026
Completion date
December 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dacryocystorhinostomy, dexmedetomidine, general anesthesia, hemodynamic effect, lidocaine, magnesium sulphate, peribulbar block